Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Medicines Co (MDCO)    
$32.99 0.33 (0.99%) as of 4:30 Fri 5/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 54,030,000 as of 12/31
Market Cap: 1.78(B)
Last Volume: 756,270 Avg Vol: 560,674
52 Week Range: $20.34 - $37.1
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY       NASDAQ COMPOSITE  
    NASDAQ NNM COMPOSITE  

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Medicines is a pharmaceutical company. Co. has three marketed products, Angiomax®, for use in the U.S., as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty and for use in patients undergoing percutaneous coronary intervention, including patients with or at risk of heparin induced thrombocytopenia (HIT) and thrombosis syndrome; Cleviprex®, for use as a blood pressure reduction; and its ready-to-use formulation of Argatroban, for treatment of thrombosis in adult patients with HIT. Co. also has a pipeline of products in development, including cangrelor, oritavancin, MDCO-157, MDCO-2010 and MDCO-216.
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 9,150
Total Buy Value $0 $0 $0 $200,385
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 165,409 520,753 679,381 763,501
Total Sell Value $5,544,664 $15,884,677 $19,690,719 $21,372,291
Total People Sold 7 8 8 9
Total Sell Transactions 15 40 50 81
End Date 2013-02-24 2012-11-23 2012-05-25 2011-05-26

   
Records found: 434
  Page 1 of 18  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sblendorio Glenn President & CFO   •       •      –    2013-05-10 4 AS $37.00 $100,233 D/D (2,709) 120,434 -4%     
   Oconnor William Bernard Sr VP & Chief Acct. Officer   •       –      –    2013-05-09 4 OE $12.95 $559,769 D/D 29,654 29,712     -
   Antinori Paul Michael Sr. VP & General Counsel   •       –      –    2013-05-09 4 AS $34.90 $1,221,500 D/D (35,000) 51,906     -
   Antinori Paul Michael Sr. VP & General Counsel   •       –      –    2013-05-09 4 OE $17.04 $633,300 D/D 35,000 56,906     -
   Oconnor William Bernard Sr VP & Chief Acct. Officer   •       –      –    2013-05-09 4 AS $35.00 $1,037,890 D/D (29,654) 25,058     -
   Meanwell Clive Chairman & CEO   •       •      –    2013-05-01 4 AS $33.47 $251,025 D/D (7,500) 357,377 9%     
   Hugin Robert J Director   –       •      –    2013-04-16 4 OE $17.19 $28,656 D/D 1,667 46,000     -
   Meanwell Clive Chairman & CEO   •       •      –    2013-04-01 4 AS $33.37 $250,275 D/D (7,500) 364,877 8%     
   Shigeta Hiroaki Director   –       •      –    2013-03-26 4 AS $33.50 $1,114,177 D/D (33,259) 18,500 7%     
   Shigeta Hiroaki Director   –       •      –    2013-03-26 4 OE $18.18 $616,199 D/D 33,259 36,759     -
   Savage Robert G Director   –       •      –    2013-03-13 4 S $31.77 $119,138 D/D (3,750) 22,250 -5%     
   Crouse William Director   –       •      –    2013-03-11 4 S $32.23 $402,875 D/D (12,500) 26,000 -3%     
   Crouse William Director   –       •      –    2013-03-11 4 OE $23.00 $287,500 D/D 12,500 38,500     -
   Meanwell Clive Chairman & CEO   •       •      –    2013-03-01 4 A $0.00 $0 D/D 65,354 379,877     -
   Meanwell Clive Chairman & CEO   •       •      –    2013-03-01 4 AS $31.56 $236,700 D/D (7,500) 372,377 14%     
   Oconnor William Bernard Sr VP & Chief Acct. Officer   •       –      –    2013-03-01 4 A $0.00 $0 D/D 10,892 25,058     -
   Sblendorio Glenn President & CFO   •       •      –    2013-03-01 4 A $0.00 $0 D/D 37,345 123,143     -
   Antinori Paul Michael Sr. VP & General Counsel   •       –      –    2013-03-01 4 A $0.00 $0 D/D 8,335 51,906     -
   Sblendorio Glenn President & CFO   •       •      –    2013-02-28 4 A $22.39 $10,613 D/D 474 85,798     -
   Antinori Paul Michael Sr. VP & General Counsel   •       –      –    2013-02-28 4 A $22.39 $4,388 D/D 196 43,571     -
   Meanwell Clive Chairman & CEO   •       •      –    2013-02-28 4 A $22.39 $10,613 D/D 474 314,523     -
   Oconnor William Bernard Sr VP & Chief Acct. Officer   •       –      –    2013-02-27 4 AS $31.09 $151,470 D/D (4,872) 14,166 14%     
   Sblendorio Glenn President & CFO   •       •      –    2013-02-26 4 S $30.85 $31,868 D/D (1,033) 85,324 -8%     
   Antinori Paul Michael Sr. VP & General Counsel   •       –      –    2013-02-25 4 S $31.22 $33,312 D/D (1,067) 43,375 -7%     
   Meanwell Clive Chairman & CEO   •       •      –    2013-02-25 4 S $31.17 $383,485 D/D (12,303) 314,049 -7%     
  434 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 18
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2010 J3SG.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us